Table 2.
Incidence of outcomes (functional decline, hospitalisation and all-cause mortality) according to diabetes overtreatment
| Outcomes at 1 year | All patients (n = 490) IR and 95% CI (cases per 100 patients-year) or % and 95%CI |
Diabetes overtreatment (n = 168; 34.3%) IR and 95% CI (cases per 100 patients-year) or % and 95%CI |
No diabetes overtreatment (n = 322; 65.7%) IR and 95% CI (cases per 100 patients-year) or % and 95%CI |
P-value |
|---|---|---|---|---|
| Mortality, IR | 25.1 (20.4; 30.5) | 32.8 (23.7; 44.2) | 21.4 (16.2; 27.6) | 0.033 |
| Hospitalisation, IR | 119.9 (109.2; 131.1) | 107.3 (90.1; 126.8) | 125.8 (112.7; 140.0) | 0.115 |
| Functional decline, %a | 35.1 (30.5; 40.0) | 29.3 (21.9; 37.9) | 38.0 (32.2; 44.0) | 0.087 |
a
Defined as a loss of ≥10% of Barthel index occurring during the follow-up among patients with at least two measurements of Barthel index (n = 407); IR: incidence rate (cases per 100 patient-years); CI: confidence interval.